PABPC1 is involved in a variety of signaling pathways involved in tumorigenesis and progression, including Nfr2 signaling, Hippo signaling and PTEN signaling (24, 29, 30), and PABPC1 may be a potential target for tumor therapy. Here, PTEN is linked to neoplasm.